ROCKWELL MEDICAL, INC. Inventory, Finished Goods, Net of Reserves
ROCKWELL MEDICAL, INC. (RMTI) had Inventory, Finished Goods, Net of Reserves of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-13
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $1.02M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $1.22M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $1.38M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $1.51M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.38M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.75M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.01M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.40M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $3.42M 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $3.27M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $2.81M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.60M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.29M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.11M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $1.80M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.99M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.33M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.96M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.78M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.94M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.98M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.80M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $1.61M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.03M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.87M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.43M 10-K · filed 2021-03-31 | $1.43M 10-K · filed 2020-03-17 |
| 2019-09-30 | $1.51M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.81M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.92M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.80M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $2.19M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.81M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.99M 10-Q/A · filed 2018-08-14 | $2.74M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.81M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $5.26M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.32M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.93M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.98M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $2.99M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.81M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.29M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.20M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $2.11M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.58M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $1.52M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.53M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $1.38M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.36M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $1.43M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.40M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $1.51M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $1.43M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $1.56M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.45M 10-K · filed 2014-03-07 | |
| 2011-12-31 | $1.51M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |